LORI DAY: Open Payments
NPI 1992268981 · BEDFORD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 32 payments from 16 companies in 2025. Trend: 2023 $12 · 2024 $376 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $84 |
| Novo Nordisk Inc | 5 | $84 |
| Exact Sciences Corporation | 3 | $57 |
| Amgen Inc. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| PFIZER INC. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
| Astellas Pharma US Inc | 1 | $24 |
Products named: VRAYLAR, OTEZLA, REXULTI, CAPLYTA, Ozempic, NURTEC ODT, The Cologuard Plus Collection Kit, BREZTRI.
Industry payments across IN — which companies pay providers there.
